OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma
Yeming Yang, Jingshu Cai, Xue Yang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2342-2353
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 60

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56

Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 43

RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 32

Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17

ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2

METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 2

IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
Xin Xu, Jiangtao Cui, Hong Wang, et al.
Materials Today Bio (2022) Vol. 17, pp. 100503-100503
Open Access | Times Cited: 61

The role of RNA m6A methylation in lipid metabolism
Yuting Wang, Yujie Wang, Jiarui Gu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway
Tianyu Jiang, Yao Xiao, Jinfeng Zhou, et al.
Redox Biology (2023) Vol. 68, pp. 102963-102963
Open Access | Times Cited: 36

The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30

IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis
Ji-Fei Ding, He Sun, Kai Song, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175494-175494
Closed Access | Times Cited: 24

N6-methyladenosine RNA methylation in diabetic kidney disease
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 10

RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10

Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases
Faiz Ali Khan, Bernard Nsengimana, Usman Ayub Awan, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 9

The role and mechanism of m6A methylation in diabetic nephropathy
Lin-Jing Yan, Liang Guo
Life Sciences (2025) Vol. 363, pp. 123355-123355
Closed Access | Times Cited: 1

RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1

METTL3 promotes the progression of non-alcoholic fatty liver disease by mediating m6A methylation of FAS
Qun-Hua Li, Jun Xiang
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer
Bin Shi, Weiwei Liu, Ke Yang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 38

ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation
Juan Wang, Yang Yang, Feng Sun, et al.
Pharmacological Research (2022) Vol. 187, pp. 106608-106608
Open Access | Times Cited: 34

ALKBH5‐Mediated RNA m6A Methylation Regulates the Migration, Invasion, and Proliferation of Rheumatoid Fibroblast‐Like Synoviocytes
Yu Kuang, Ruiru Li, Jingnan Wang, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 2, pp. 192-205
Open Access | Times Cited: 20

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
Runping Liu, Yajing Li, Qi Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1009-1029
Open Access | Times Cited: 20

FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4
Ziyi Wang, Hongyu Li, Hongshi Cai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16339-16339
Open Access | Times Cited: 19

Page 1 - Next Page

Scroll to top